BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Kidney Transplant Rejection readouts · AssetMemo
X-WR-CALDESC:Upcoming phase 1/2 and later readouts in Kidney Transplant Rej
 ection\, from ClinicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07204080-10831@assetmemo.bio
DTSTAMP:20261121T004948Z
DTSTART;VALUE=DATE:20310901
DTEND;VALUE=DATE:20310902
SUMMARY:TNX-1500: Phase 2 readout est. (NCT07204080)
DESCRIPTION:TNX-1500\, phase 2\, Kidney Transplant Rejection.\nStudy: (TNX-
 1500) in Kidney Transplant Recipients\nEstimated primary completion: 1 Sep
 tember 2031. This is a ClinicalTrials.gov estimate\, not a confirmed reado
 ut date\, and it can move.\nDrug page: https://assetmemo.bio/drug/tnx-1500
 #upcoming-events\nRegistry record: https://clinicaltrials.gov/study/NCT072
 04080
URL:https://assetmemo.bio/drug/tnx-1500#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
